{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:16:09Z","timestamp":1791353769897,"version":"4.3.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T00:00:00Z","timestamp":1353888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T00:00:00Z","timestamp":1353888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/bmt.2012.234","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T11:45:05Z","timestamp":1353930305000},"page":"837-842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation"],"prefix":"10.1038","volume":"48","author":[{"given":"G W","family":"Basak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L C","family":"de Wreede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"van Biezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Wiktor-Jedrzejczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Halaburda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"von dem Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abayomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Volin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Buzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bunjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Olavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chronic Malignancies Working Party EBMT.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,26]]},"reference":[{"key":"BFbmt2012234_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beha.2009.05.002","volume":"22","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Heim D . Current role of stem cell transplantation in chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22: 431\u2013443.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbmt2012234_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bmt.2011.11","volume":"46","author":"H Baldomero","year":"2011","unstructured":"Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011; 46: 485\u2013501.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012234_CR3","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","volume":"23","author":"Stem Cell Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Stem Cell Trialists\u2019 Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074\u20135087.","journal-title":"J Clin Oncol"},{"key":"BFbmt2012234_CR4","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1182\/blood-2006-05-024042","volume":"108","author":"N Schmitz","year":"2006","unstructured":"Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 4288\u20134290.","journal-title":"Blood"},{"key":"BFbmt2012234_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","volume":"13","author":"M Eapen","year":"2007","unstructured":"Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007; 13: 1461\u20131468.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012234_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V100.2.397","volume":"100","author":"C Guglielmi","year":"2002","unstructured":"Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 2002; 100: 397\u2013405.","journal-title":"Blood"},{"key":"BFbmt2012234_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins","year":"1997","unstructured":"Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BFbmt2012234_CR8","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","volume":"91","author":"EP Alyea","year":"1998","unstructured":"Alyea EP, Soiffer RJ, Canning C, Neuberg D, Schlossman R, Pickett C et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671\u20133680.","journal-title":"Blood"},{"key":"BFbmt2012234_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.thj.6200051","volume":"1","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Hasserjian R, Gordon MY, Boecklin F, Cotter F, Corbo M et al. Normal and chronic phase CML hematopoietic cells repopulate NOD\/SCID bone marrow with different kinetics and cell lineage representation. Hematol J 2000; 1: 307\u2013315.","journal-title":"Hematol J"},{"key":"BFbmt2012234_CR10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V99.4.1130.h8001130_1130_1135","volume":"99","author":"AH Elmaagacli","year":"2002","unstructured":"Elmaagacli AH, Basoglu S, Peceny R, Trenschel R, Ottinger H, Lollert A et al. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia. Blood 2002; 99: 1130\u20131135.","journal-title":"Blood"},{"key":"BFbmt2012234_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/bbmt.2001.v7.pm11215696","volume":"7","author":"S Carlens","year":"2001","unstructured":"Carlens S, Remberger M, Aschan J, Ringden O . The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol Blood Marrow Transplant 2001; 7: 31\u201338.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012234_CR12","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.V96.8.2712","volume":"96","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Cross NC, Craddock C, Kaeda J, Kanfer E et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2000; 96: 2712\u20132716.","journal-title":"Blood"},{"key":"BFbmt2012234_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.bmt.1703883","volume":"31","author":"AM Raiola","year":"2003","unstructured":"Raiola AM, Van Lint MT, Valbonesi M, Lamparelli T, Gualandi F, Occhini D et al. Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions. Bone Marrow Transplant 2003; 31: 687\u2013693.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2012234_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10245330512331390122","volume":"10","author":"HJ Kolb","year":"2005","unstructured":"Kolb HJ, Schmid C, Buhmann R, Tischer J, Ledderose G . DLI: where are we know? Hematology 2005; 10 (Suppl 1): 115\u2013116.","journal-title":"Hematology"},{"key":"BFbmt2012234_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.leu.2404641","volume":"21","author":"MP Simula","year":"2007","unstructured":"Simula MP, Marktel S, Fozza C, Kaeda J, Szydlo RM, Nadal E et al. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia 2007; 21: 943\u2013948.","journal-title":"Leukemia"},{"key":"BFbmt2012234_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(84)92179-2","volume":"1","author":"B Speck","year":"1984","unstructured":"Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB et al. Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet 1984; 1: 665\u2013668.","journal-title":"Lancet"},{"key":"BFbmt2012234_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/bmt.2009.177","volume":"45","author":"Y Chalandon","year":"2010","unstructured":"Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP et al. Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant 2010; 45: 558\u2013564.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012234_CR18","volume-title":"Using and Understanding Medical Statistics","author":"DE Matthews","year":"1996","unstructured":"Matthews DE, Farewell VT . Using and Understanding Medical Statistics. Karger: Basel, 1996."},{"key":"BFbmt2012234_CR19","unstructured":"European Group for Blood and Marrow Transplantation Internet access: ProMISe. Available from www.ebmt.org\/Contents\/Data-Management\/Registrystructure\/ DatamanagementsystemProMIse\/Pages\/Data-management-system-ProMIse.aspx (Accessed on 21 September 2012)."},{"key":"BFbmt2012234_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bmt.1705167","volume":"36","author":"BN Savani","year":"2005","unstructured":"Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ . Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1009\u20131015.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012234_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","volume":"11","author":"B Friedrichs","year":"2010","unstructured":"Friedrichs B, Tichelli A, Bacigalupo A, Russell NH, Ruutu T, Shapira MY et al. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol 2010; 11: 331\u2013338.","journal-title":"Lancet Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012234","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:17:22Z","timestamp":1648048642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,26]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFbmt2012234"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.234","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,26]]},"assertion":[{"value":"18 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}